HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Rep. Pallone Demands Answers From FDA On Seeming Hair-Smoothing Formaldehyde Ban ‘Reversal’

Executive Summary

Internal FDA emails obtained by the Environmental Working Group through a FOIA request indicate that the agency was moving toward rulemaking in 2016 to restrict or prohibit use of formaldehyde in heated hair-straightening cosmetics, but seemingly abandoned the initiative. That has Congress, NGOs and other stakeholders asking questions and renewing calls for cosmetics regulatory reform.

You may also be interested in...



US FDA Chief Scientist Bumpus Takes On Health Disparities, Formaldehyde In Hair Straighteners

New leadership overseeing the US Food and Drug Administration’s Office of Cosmetics and Colors has kickstarted a long-sought rulemaking to address formaldehyde and formaldehyde releasers in hair straightening products, with a proposed ban in mind.

US FDA Inaction On Formaldehyde In Hair-Smoothing Products ‘Unconscionable,’ Petitioners Say

The Environmental Working Group and Women’s Voices for the Earth try again with a petition to the US Food and Drug Administration seeking a ban on use of formaldehyde and equivalents in heated hair-straightening products. This time they are joined by 75 concerned salon workers.

Cosmetics Industry Should ‘Double Down’ On Self-Regulation While Awaiting Reform Legislation

Covington & Burling attorney Peter Barton Hutt brings historical perspective to the matter of cosmetics reform legislation in US Congress, which stalled out in 2020 after COVID hit the states. He advises companies to continue working to meet and exceed existing regulatory requirements "so that people can’t say that voluntary self-regulation doesn’t work."

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150620

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel